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In this issue of the Journal, Mallbris et al (2005) describe an
effect of sunlight on the human innate immune system that
could be of great clinical significance. The Karolinska team
reports that the UVB band of ultraviolet light stimulates ex-
pression of hCAP18, the precursor of the antimicrobial
peptide LL-37, in human skin. The group conducted a clin-
ical study in which they exposed the skin of eight individuals
to a minimal erythematous dose of both UVA (300–400 nm)
and UVB (280–315 nm) wavelengths, at separate body
sites, and biopsied these sites 24 h after exposure (as well
as prior to UV exposure). These biopsies were then analy-
zed for the abundance of hCAP18 mRNA and Vitamin D
receptor protein. The investigators report that each of the
individuals exposed to UVB light exhibited an increase in
the amount of both hCAP 18 mRNA and Vitamin D receptor
in their skin. A positive correlation between induction of the
skin antimicrobial peptide and the Vitamin D receptor was
noted, suggesting that hCAP18 expression was influenced
positively by the increase in Vitamin D receptor levels. The
effect was not observed following UVA exposure. The mag-
nitude of the response appeared not to correlate with the
complexion of the individual (e.g., people who tan easily
and rarely burn in sun vs those who tan poorly and sunburn
easily). There was a surprising variation among individual
responses in both the magnitude of the response to UV
exposure as well as with respect to the levels of both
hCAP18 mRNA and vitamin D receptor protein measured in
the unexposed skin.
This report follows a prior clinical study by the same team
(Weber et al, 2005) in which the topical administration of a
Vitamin D analog (calcipotriol) onto the skin of volunteers
was shown to increase the expression of fully processed LL
37 peptide within 24 h of administration. The authors dem-
onstrated in vitro that the responsiveness of the hCAP18
gene in human keratinocytes to Vitamin D was dependent
on the presence of a Vitamin D receptor-DNA binding se-
quence located about 500 nucleotides upstream from the
gene, confirming an earlier study conducted in vitro by an-
other group (Wang et al, 2004). In vitro, both 1,25 dihydroxy
Vitamin D3 and 25 hydroxy Vitamin D3, but not the Vitamin D
precursor 7 dehydrocholesterol (7DHC) exhibited stimula-
tory activity.
Together, these reports strongly suggest that exposure of
human skin to UVB light can stimulate expression of the
antimicrobial peptide LL 37, likely through a chain of events
that involves Vitamin D.
The discovery that sunlight, through the mediation of Vi-
tamin D, activates an arm of innate immunity within the skin
of man could have far-ranging implications with respect to
our understanding of certain human skin conditions and
their treatment.
Caucasians are surprisingly prone to sunburn. Ultraviolet
radiation within the UVB bandwidth causes photochemical
alterations in both the DNA and membrane lipids of epider-
mal cells (Halliday, 2005). Furthermore, low doses of UVB
appear to coordinately suppress keratinocyte proliferation
and stimulate cellular maturation. Surprisingly, low doses of
UVB also suppress certain arms of the adaptive immune
system (Halliday, 2005). For example, UVB treatment de-
presses acute and delayed hypersensitivity reactions. Cer-
tain chronic inflammatory skin conditions, such as psoriasis,
are treated with measured doses of UVB, in part for this
reason. UVB is believed to cause immunosuppression by
direct action on immune cells within the skin, as well as
indirectly. Vitamin D, converted by UVB in skin from 7DHC
has potent immunosuppressant properties. Indeed, the ac-
tive forms of Vitamin D have been shown to inhibit T cell
proliferation, inhibit expression of MHC class II proteins on
antigen presenting cells, and depress the activity of La-
ngerhans cells (Lehmann et al, 2004). In addition, sunlight
stimulates the keratinocyte and the melanocyte to express
aMSH, a hormone that not only plays a role in the pigmen-
tation of skin but also serves to suppress epidermal inflam-
mation (Brogden et al, 2005).
Thus, sunlight, which so readily damages skin normally,
also ‘‘quiets’’ the adaptive immune system within the skin, in
part through the activation of the Vitamin D signaling path-
way. We presume that without the induction of UVB-
associated immunosuppression we would suffer severe in-
flammation following ‘‘normal’’ exposure to sunlight. The
reports by Mallbris et al, Weber et al, and Wang et al tell us
that while the adaptive system is being ‘‘toned down’’, UVB,
via the Vitamin D pathway, also causes a ‘‘non-inflamma-
tory’’ antimicrobial component of the innate immune system
to be ‘‘turned on’’.
LL-37 is one of several abundant antimicrobial peptides
expressed by the keratinocytes and the epidermal glands of
man (Gallo, 2005). Antimicrobial peptides are widely ex-
pressed throughout nature and provide a means by which
multicellular organisms can defend themselves rapidly
against microbial assault (Zasloff, 2002). In mammals, most
antimicrobial peptides appear to be synthesized in epider-
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mal layers above the stem cell layer and accumulate within
the superficial layers of the epidermis and on the skin
surface. Several antimicrobial peptides such as LL-37,
b-defensins 2 and 3, and psoriasin are inducible, usually
following skin injury or exposure to microbial products
(Gallo, 2005). It is also likely that antimicrobial peptides play
an important role in the control of microbial flora on the
intact and damaged epithelial surface, both by suppressing
the growth of certain microorganisms and by ‘‘stabilizing’’
the numbers and diversity of commensal flora (Zasloff,
2002). In addition to their anti-infective activity, antimicrobial
peptides exhibit biological activities that provide benefit in
the setting of skin injury, such as attraction for certain im-
mune cells, epithelial repair, and angiogenesis (Koczulla
et al, 2003). In certain diseases, like psoriasis, intense ex-
pression of several antimicrobial peptides is noted; pre-
sumably, for this reason, skin infections in this condition are
rarely observed. In atopic dermatitis (Gallo, 2005), in con-
trast, as well as in chronic leg ulcers (Heilborn et al, 2003)
and thermal burns (Gallo, 2005), depressed expression of
antimicrobial peptides has been reported, likely to be the
mechanism underlying the association of the infections that
frequently complicate these skin conditions.
The observation by Mallbris et al that UVB stimulates
expression of LL-37 in epidermis is not without some sur-
prise. It leads us to speculate that acute exposure of the
skin to sunlight might tip the ‘‘immune balance’’ in favor of
innate immune defense. Functional deficits in the defense of
the skin against microbes caused by suppression of local
adaptive immunity could be compensated for by stimulation
of antimicrobial peptide expression (see Fig 1). We note that
UVB can stimulate innate immunity in yet other ways.
aMSH, although a potent immunosuppressant itself—as
well as a ‘‘hormone’’ or ‘‘neuropeptide’’—also has, inde-
pendently, potent antifungal activity; thus, stimulation of
‘‘tanning’’ is accompanied by the generation of local anti-
fungal defenses. Pain, associated with sunburn, involves
stimulation of nocioceptive C-type fibers in the epidermis,
which release substance P when activated. Substance P is
a potent pro-inflammatory peptide with neutrophil attractant
properties. Substance P also exhibits direct antimicrobial
activity, suggesting that when pain is associated with sun-
burn damage, sensory nerves are discharged to further
coordinate specific defensive scenarios within the innate
branch of immunity (Brogden et al, 2005).
This report provokes many questions and thoughts. In
the study reported by Malbris et al epidermal hCAP18 ex-
pression ranged over 100 fold across the study population,
in both unexposed skin and at sites exposed to UVB light.
Do these variations relate to the proclivity of an individual
to skin cancer? Many natural and synthetic antimicrobial
peptides exhibit cytotoxic activity against transformed cells
(Gallo, 2005), likely a result of the enrichment of anion
phospholipids on their surface; might those individuals who
respond to UV exposure with ‘‘robust’’ expression of LL-37
stand a lesser chance of having a transformed cell survive in
the epidermis than those that rely more heavily on activation
of an adaptive immune response to clear the cancerous
cell? In addition to LL-37, which other antimicrobial pep-
tides are induced by Vitamin D and UVB? Would the judi-
cious use of Vitamin D reduce inflammation and/or scarring
in the setting of epidermal wound repair by augmenting
antimicrobial peptide expression? Burns appear to predis-
pose to a state of Vitamin D deficiency, due to a depression
of Vitamin D synthesis in both damaged and uninjured skin
caused by an unknown mechanism (Klein et al, 2004). Are
burn victims generally impaired in antimicrobial peptide ex-
pression? Should we consider treatment of burn victims
with topical Vitamin D? The diabetic foot ulcer and the ve-
nous stasis ulcer are chronic wounds often complicated by
complex polymicrobial infections. Would the judicious use
of either UVB or Vitamin D prior to skin breakdown in pa-
tients pre-disposed to these wounds (to stimulate local ex-
pression of LL-37) alter the natural history of their skin
disease? Since atopic dermatitis has been associated with
depressed expression of LL-37, should judicious use of
Vitamin D and/or UVB be considered?
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